Jun An Lu
Director/Board Member at EpimAb Biotherapeutics, Inc.
Profile
Jun An Lu currently works at EpimAb Biotherapeutics, Inc., as Director.
Mr. Lu also formerly worked at Inmyshow Digital Technology (Group) Co., Ltd., as Securities Representative.
Jun An Lu active positions
| Companies | Position | Start |
|---|---|---|
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Director/Board Member | - |
Former positions of Jun An Lu
| Companies | Position | End |
|---|---|---|
| INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD. | Investor Relations Contact | 25/01/2017 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INMYSHOW DIGITAL TECHNOLOGY(GROUP)CO.,LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Health Technology |
- Stock Market
- Insiders
- Jun An Lu
